| Name | Mini-cassia Care Center |
|---|---|
| Location | 1729 Miller Avenue, Burley, Idaho |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 68 |
| Occupancy Rate | 67.94% |
| Medicare ID (CCN) | 135081 |
| Legal Business Name | Charolais Care I, Inc |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1003803024 |
| Organization Name | NORTHWEST BEC CORP DBA BURLEY CARE CENTER |
| Address | 1729 Miller Ave, Burley, ID 83318 |
| Phone Number | 208-678-9474 |
News Archive
The SARS coronavirus 2 (SARS-CoV-2) infects lung cells and is responsible for the COVID-19 pandemic. The viral spike protein mediates entry of the virus into host cells and harbors an unusual activation sequence.
This Tuesday (6th June 2017) the World Health Organization came out with a recommendation that some antibiotics should be kept in reserve as the last resort in superbug infections due to the risk of antibiotic resistance worldwide.
A new study assesses antibody and functional T-cell responses at 6 months after complete vaccination with the Pfizer-BioNTech vaccine.
A new study by UCLA scientists has found that the breakthrough immunotherapy drug pembrolizumab can be more effective in improving survival in people with non-small cell lung cancer (NSCLC) if they have previously received radiation therapy, compared to those without a history of radiation treatment.
› Verified 8 days ago
| NPI Number | 1285882431 |
| Organization Name | CHAROLAIS CARE I, INC |
| Doing Business As | MINI-CASSIA CARE CENTER |
| Address | 1729 Miller Ave, Burley, ID 83318 |
| Phone Number | 208-678-9474 |
News Archive
The SARS coronavirus 2 (SARS-CoV-2) infects lung cells and is responsible for the COVID-19 pandemic. The viral spike protein mediates entry of the virus into host cells and harbors an unusual activation sequence.
This Tuesday (6th June 2017) the World Health Organization came out with a recommendation that some antibiotics should be kept in reserve as the last resort in superbug infections due to the risk of antibiotic resistance worldwide.
A new study assesses antibody and functional T-cell responses at 6 months after complete vaccination with the Pfizer-BioNTech vaccine.
A new study by UCLA scientists has found that the breakthrough immunotherapy drug pembrolizumab can be more effective in improving survival in people with non-small cell lung cancer (NSCLC) if they have previously received radiation therapy, compared to those without a history of radiation treatment.
› Verified 8 days ago
| NPI Number | 1770890022 |
| Organization Name | MINI-CASSIA CARE CENTER LLC |
| Address | 1729 Miller Ave, Burley, ID 83318 |
| Phone Number | 208-678-9474 |
News Archive
The SARS coronavirus 2 (SARS-CoV-2) infects lung cells and is responsible for the COVID-19 pandemic. The viral spike protein mediates entry of the virus into host cells and harbors an unusual activation sequence.
This Tuesday (6th June 2017) the World Health Organization came out with a recommendation that some antibiotics should be kept in reserve as the last resort in superbug infections due to the risk of antibiotic resistance worldwide.
A new study assesses antibody and functional T-cell responses at 6 months after complete vaccination with the Pfizer-BioNTech vaccine.
A new study by UCLA scientists has found that the breakthrough immunotherapy drug pembrolizumab can be more effective in improving survival in people with non-small cell lung cancer (NSCLC) if they have previously received radiation therapy, compared to those without a history of radiation treatment.
› Verified 8 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
The SARS coronavirus 2 (SARS-CoV-2) infects lung cells and is responsible for the COVID-19 pandemic. The viral spike protein mediates entry of the virus into host cells and harbors an unusual activation sequence.
This Tuesday (6th June 2017) the World Health Organization came out with a recommendation that some antibiotics should be kept in reserve as the last resort in superbug infections due to the risk of antibiotic resistance worldwide.
A new study assesses antibody and functional T-cell responses at 6 months after complete vaccination with the Pfizer-BioNTech vaccine.
A new study by UCLA scientists has found that the breakthrough immunotherapy drug pembrolizumab can be more effective in improving survival in people with non-small cell lung cancer (NSCLC) if they have previously received radiation therapy, compared to those without a history of radiation treatment.
› Verified 8 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 1 |
| Total Amount of Fines in Dollars | $6500 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 1 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 22.28 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 9.62 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 54.1 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 1.92 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 2.69 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 91.4 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 47.27 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 36.11 | 83.88 |